首页 > 市场调查报告书 > 医疗设备

病患监测呼吸器

智慧气喘监测设备市场规模、份额及成长分析（按产品、应用及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900458

智慧气喘监测设备市场规模、份额及成长分析（按产品、应用及地区划分）－2026-2033年产业预测

Intelligent Asthma Monitoring Devices Market Size, Share, and Growth Analysis, By Product (Wearable Asthma Monitoring Devices, Smart Inhalers), By End Use (Hospitals, Clinics), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球智慧气喘监测设备市场规模预计到 2024 年将达到 8.1133 亿美元，从 2025 年的 10.1903 亿美元增长到 2033 年的 63.1106 亿美元，在预测期（2026-2033 年）内复合年增长率为 25.6%。

由于空气污染日益严重、人们对室内污染物的敏感性增加以及慢性阻塞性肺病（COPD）和气喘盛行率上升，智慧气喘监测设备市场正经历显着增长。推动这一增长的关键因素包括智慧吸入器的日益普及、以患者为中心的医疗模式的转变以及製药公司和医疗器材製造商之间合作的加强。医疗保健领域的先进数位设备旨在提醒用户潜在的气喘发作，并监测用药依从性和追踪用药时间。行动医疗应用程式、穿戴式装置和个人监测工具的整合展现出巨大的潜力，有望改善气喘管理，最终有助于提高气喘患者的治疗效果和生活品质。

全球智慧气喘监测设备市场驱动因素

全球污染程度显着上升是气喘盛行率不断攀升的主要因素，也因此推动了对智慧气喘监测设备的需求。包括气喘在内的慢性呼吸系统疾病影响着全球数百万人口，这使得先进的监测解决方案变得至关重要。人们对这些设备益处的认识不断提高，加之技术的快速发展和产业关注度的提升，进一步推动了市场扩张。智慧吸入器，例如干粉吸入器和定量喷雾吸入器，正受到希望加强气喘管理和提高药物疗效的主要企业的青睐。这种日益增长的认知和创新对于支撑不断变化的市场格局至关重要。

限制全球智慧气喘监测设备市场的因素

全球污染日益加剧，导致气喘发病率不断上升，凸显了对价格合理、技术先进的监测设备的迫切需求，这些设备能够鼓励患者积极参与自我护理。然而，大众对智慧吸入器和雾化器的功能和益处认知不足，阻碍了全球智慧气喘监测设备市场的发展。这种认知差距使得患者无法充分利用这些创新工具，进而影响气喘管理和健康状况的改善。弥合这一认知差距对于市场扩张和提升患者照护至关重要。

全球智慧型气喘监测设备市场趋势

随着人们对呼吸系统健康的日益关注以及气喘在全球范围内的盛行率不断上升，全球智慧气喘监测设备市场正经历显着成长。诸如智慧型贴片等创新产品代表市场的发展趋势，其采用的先进穿戴式技术能够持续监测咳嗽、呼吸频率和喘息等症状。这些智慧型设备不仅透过震动回馈提醒用户注意异常情况，还能透过通知功能帮助用户与看护者及时沟通。随着消费者越来越重视个人化的健康管理解决方案，对高度互联且易于使用的气喘监测技术的需求激增，推动了市场扩张，并促进了呼吸系统疾病预防保健的转变。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Adherium Limited（New Zealand）
AstraZeneca plc（United Kingdom）
Boehringer Ingelheim International GmbH（Germany）
Cohero Health, Inc.（United States）
GlaxoSmithKline plc（United Kingdom）
Health Care Originals, Inc.（United States）
Koninklijke Philips NV（Netherlands）
Teva Pharmaceutical Industries Ltd.（Israel）
Vectura Group plc（United Kingdom）
Volansys Technologies Pvt. Ltd.（India）
3M（United States）
AEvice Health（Singapore）
Respiri Limited（Australia）
Quvium（United States）
Findair（Poland）
Sensirion AG（Switzerland）
Thorasys Thoracic Medical Systems Inc.（Canada）
Vitalograph Ltd.（Ireland）
Zephyr Sleep Technologies（Canada）

结论与建议

简介目录

Product Code: SQMIG35C2023

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 811.33 Million in 2024 and is poised to grow from USD 1019.03 Million in 2025 to USD 6311.06 Million by 2033, growing at a CAGR of 25.6% during the forecast period (2026-2033).

The market for intelligent asthma monitoring devices is experiencing notable growth driven by rising air pollution, increasing sensitivity to indoor pollutants, and the escalating prevalence of COPD and asthma. Key factors fostering this expansion include the growing adoption of smart inhalers, the shift toward patient-centered healthcare models, and enhanced collaboration between pharmaceutical firms and device manufacturers. Advanced digital devices in healthcare are designed to alert users to potential asthma attacks, while also monitoring medication adherence and tracking dosing times. The integration of mobile health applications, wearables, and personal monitoring tools underscores the significant potential for improving asthma management, ultimately contributing to better patient outcomes and enhanced quality of life for individuals living with asthma.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intelligent Asthma Monitoring Devices Market Segments Analysis

Global Intelligent Asthma Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into wearable asthma monitoring devices, smart inhalers, inhalers, dry powdered inhalers (DPI's), metered dose inhalers (MDI's) and nebulizers. Based on end use, the market is segmented into hospitals, clinics, home use and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intelligent Asthma Monitoring Devices Market

The significant rise in global pollution levels is a primary driver for the increasing prevalence of asthma, leading to heightened demand for intelligent asthma monitoring devices. Chronic respiratory issues, including asthma, affect millions globally, prompting a critical need for advanced monitoring solutions. The awareness regarding the benefits of these devices, coupled with rapid technological advancements and heightened industry focus, is further stimulating market expansion. Smart inhalers, such as dry powdered inhalers and metered dose inhalers, are gaining traction among leading companies aiming to enhance asthma management and improve medication efficacy. This growing recognition and innovation is crucial for supporting the evolving market landscape.

Restraints in the Global Intelligent Asthma Monitoring Devices Market

The increasing pollution levels worldwide contribute to a higher incidence of asthma, highlighting the urgent demand for affordable and advanced monitoring devices to encourage patients to actively engage in their self-care routines. However, the growth of the global intelligent asthma monitoring devices market is hindered by a general lack of awareness regarding the functionality and benefits of smart inhalers and nebulizers. This gap in understanding prevents patients from fully utilizing these innovative tools, which could otherwise enhance their asthma management and overall health outcomes. Addressing this knowledge deficiency is crucial for the market's expansion and the improvement of patient care.

Market Trends of the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market is experiencing significant growth as a result of rising awareness regarding respiratory health and the increasing prevalence of asthma worldwide. Innovations such as the ADAMM smart patch exemplify the market's evolution with advanced wearables that continuously monitor symptoms like cough, respiration rate, and wheezing. These intelligent devices not only alert users to deviations from normal patterns through vibrational feedback but also facilitate timely communication with caregivers via notifications. As consumers prioritize personalized health management solutions, the demand for connected, user-friendly asthma monitoring technologies is surging, driving market expansion and fostering a shift toward proactive respiratory care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis

Global Intelligent Asthma Monitoring Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Wearable Asthma Monitoring Devices
Smart Inhalers
Inhalers
Dry Powdered Inhalers (DPI's)
Metered Dose Inhalers (MDI's)
Nebulizers

Global Intelligent Asthma Monitoring Devices Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Home Use
Others

Global Intelligent Asthma Monitoring Devices Market Size & CAGR (2026-2033)

North America (Product, End Use)
- US
- Canada
Europe (Product, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Adherium Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohero Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Care Originals, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Volansys Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AEvice Health (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Respiri Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quvium (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Findair (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensirion AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thorasys Thoracic Medical Systems Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitalograph Ltd. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zephyr Sleep Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments